The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 510.00
Bid: 509.00
Ask: 510.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.196%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 510.00
BAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Final Terms

4 Oct 2016 12:46

RNS Number : 6499L
Babcock International Group PLC
04 October 2016
 

Babcock International Group PLC ("Babcock" or "the Group")

4 October 2016

BABCOCK ANNOUNCES PUBLICATION OF FINAL TERMS

The final terms dated 3 October 2016 (the "Final Terms") relating to the issue by Babcock on 5 October 2016 of GBP 250,000,000 1.875 per cent notes due 2026 (the "Notes") have been submitted to the UK Listing Authority and are available for viewing.

The Notes have been issued pursuant to the base prospectus dated 19 September 2016 (the "Base Prospectus") relating to the £1,800,000,000 Euro Medium Term Note Programme (the "Programme") of Babcock.

To view the full document, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/6499L_-2016-10-4.pdf

A copy of the Final Terms has been submitted to the National Storage Mechanism and will be available at www.morningstar.co.uk/uk/NSM.

For further information, please contact:

Kate Hill - Head of Investor Relations

Babcock International Group PLC

Address: 33 Wigmore Street, London W1U 1QX

 

Telephone: +44 207 355 5314

 

Email: kate.hill@babcockinternational.com

 

DISCLAIMER - INTENDED ADDRESSEES

This announcement is not for distribution in the United States.

Please note that the information contained in the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Final Terms) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed. Prior to relying on the information contained in the Final Terms you must ascertain from the Final Terms whether or not you are part of the intended addressees of, and eligible to view, the information contained therein.

In particular, neither this announcement nor the Final Terms shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.

The securities described in the Final Terms have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"). Subject to certain exceptions, the securities may not be offered, sold or delivered within the United States or to, or for the account or benefit of U.S. persons. The securities are being offered and sold outside of the United States in reliance on Regulation S of the Securities Act. There will be no public offering in the United States.

Your right to access this service is conditional upon complying with the above requirements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFTFZLFBQBFZFBZ
Date   Source Headline
2nd Dec 20204:24 pmRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNSHalf-year results
10th Nov 20207:00 amRNSDirector appointment
28th Oct 20207:00 amRNSAppointment of Chief Corporate Affairs Officer
15th Oct 20209:38 amRNSHolding(s) in Company
13th Oct 20209:00 amRNSChief Innovation & Technology Officer Appointment
9th Oct 20209:00 amRNSType 31 briefing
6th Oct 202011:21 amRNSHolding(s) in Company
30th Sep 202012:47 pmRNSDirector/PDMR Shareholding
30th Sep 20207:00 amRNSBabcock appoints new Chief Financial Officer
21st Sep 20202:56 pmRNSDirector/PDMR Shareholding
15th Sep 202010:20 amRNSDirector/PDMR Shareholding
9th Sep 20208:00 amRNSPublication of Base Prospectus
25th Aug 20209:25 amRNSHolding(s) in Company
18th Aug 20209:44 amRNSHolding(s) in Company
17th Aug 20209:11 amRNSDirector/PDMR Shareholding
14th Aug 20203:40 pmRNSDirector/PDMR Shareholding
14th Aug 20203:39 pmRNSDirector/PDMR Shareholding
4th Aug 20201:39 pmRNSDirector/PDMR Shareholding
4th Aug 202011:33 amRNSResult of AGM
4th Aug 202011:01 amRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSTrading update
31st Jul 20207:00 amRNSDirectorate Change
16th Jul 20209:07 amRNSDirector/PDMR Shareholding
16th Jul 20209:05 amRNSDirector/PDMR Shareholding
16th Jul 20209:05 amRNSDirector/PDMR Shareholding
7th Jul 202011:04 amRNSHolding(s) in Company
7th Jul 202011:02 amRNSHolding(s) in Company
1st Jul 20204:50 pmRNSNotice of AGM
1st Jul 202010:26 amRNSDirector/PDMR Shareholding
1st Jul 20207:00 amRNSBabcock appoints new Chief Executive
11th Jun 20203:52 pmRNSDirector/PDMR Shareholding
11th Jun 20207:00 amRNSFinal Results
19th May 20207:00 amRNSItalian Anti-Trust Authority decision
11th May 20207:00 amRNSRevised date for full year results and AGM
20th Apr 20207:00 amRNSDirector appointment
6th Apr 20207:00 amRNSUpdate on Coronavirus (COVID-19)
19th Mar 20202:47 pmRNSDirector/PDMR Shareholding
6th Mar 20209:43 amRNSSale of Context
14th Feb 202011:23 amRNSHolding(s) in Company
12th Feb 202010:33 amRNSDirector/PDMR Shareholding
12th Feb 20207:00 amRNSTrading Update
5th Feb 20207:00 amRNSDirectorate Changes
20th Jan 20201:52 pmRNSDirector/PDMR Shareholding
16th Jan 20209:13 amRNSDirector Declaration
25th Nov 201912:41 pmRNSContract for Australian Future Submarine programme
20th Nov 201910:55 amRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSHalf-year Report
15th Nov 20192:13 pmRNSType 31 Contract Win
25th Sep 20197:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.